Cuprina Holdings (Cayman) Limited (CUPR) vs Regentis Biomaterials Ltd. (RGNT)

Cuprina Holdings (Cayman) Limited and Regentis Biomaterials Ltd. are both Medical Instruments & Supplies companies. Regentis Biomaterials Ltd. is the larger, with a market value of $15.8M against $10.6M — 1.5× the size. Across the 4 metrics below, Cuprina Holdings (Cayman) Limited leads on 2 and Regentis Biomaterials Ltd. on 2.

Valuation

Metric CUPR RGNT Medical Instruments & Supplies median
P/E — — 34.17
P/S — — 2.83
P/B n/m n/m 2.82
Price to free cash flow — n/m 25.69
EV/EBITDA n/m n/m 16.08
EV/Sales n/m n/m 3.06
Earnings yield — — (1.84%)
Free cash flow yield — 0.00% 0.17%

Profitability

Metric CUPR RGNT Medical Instruments & Supplies median
Gross margin — — 54.62%
Operating margin — — 1.64%
Net margin — — 0.00%
Free cash flow margin — 0.00% 1.61%
Return on equity — 0.00% 0.00%
Return on assets — 0.00% 0.00%
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CUPR RGNT Medical Instruments & Supplies median
Revenue growth (TTM) — — 9.20%
EPS growth (last fiscal year) (200.00%) (1,504.65%) —
Revenue growth, 5-year CAGR — — 9.48%
Net income growth, 5-year CAGR — — 0.00%

Health

Metric CUPR RGNT Medical Instruments & Supplies median
Debt to equity 0.07 0.00 0.08
Current ratio 2.35 5.62 2.49
Net debt to EBITDA 0.57 0.89 0.83

Dividend

Metric CUPR RGNT Medical Instruments & Supplies median
Dividend yield — — 0.99%
Payout ratio — — 0.00

Size

Metric CUPR RGNT Medical Instruments & Supplies median
Market cap 10.64m 15.82m 938.39m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack